Atorvastatin Calcium Tablets USP, 10 mg recall — FDA D-0017-2026
Failed Dissolution Specifications
Complete FDA and NHTSA recall records dated in October 2025.
These records include useful source details for the selected month.
Failed Dissolution Specifications
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity,…
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength…
Product is missing the ingredient list (which lead to missing wheat and Yellow No. 6), and a nutritional panel.
Undeclared Yellow #5
Product label contains conflicting statements about inclusion and being free of Soy ingredient.
Undeclared Milk. During production the firm discovered that the ingredients "cheese and butter" is not listed in the ingredient statement and therefore the allergen milk was not listed in…
Potential yeast contamination.
Undeclared Yellow #5
Undeclared allergen (wheat).
Undeclared Yellow #5
Microbial contamination with Escherichia coli O7:K1 and E. Coli 1303.
Listeria monocytogenes. Recall was initiated after being notified by green onion supplier of a Listeria monocytogenes positive test result in the green onions which were used only in Ahi…
Undeclared Milk. During production the firm discovered that the ingredients "cheese and butter" is not listed in the ingredient statement and therefore the allergen milk was not listed in…
Shell egg product potentially contaminated with salmonella.
Lack of Assurance of Sterility
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk…
Lack of Assurance of Sterility
cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk…
CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Failed Content Uniformity Specifications
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.